Profile: Becton, Dickinson & Co., manufactures and distributes a broad range of medical supplies, devices, laboratory equipment and diagnostic products. Our product BD Soluvia™ is a prefillable microinjection system that is integrated with a tiny BD™ microneedle. It allows a drug or vaccine to be accurately delivered intradermally. This has proven to offer a simple, reliable delivery method. The dermal layer contains a dense network of lymphatic vessels feeding local lymph nodes, resulting in rapid & efficient therapeutic response. It also contains a high concentration of potent immune cells that play a key role to initiate the immune response following vaccination.

The company has revenues of USD 10-25 Million, has ~1600 employees and is ISO 9000, CE certified. NYSE:BDX (SEC Filings)

FDA Registration Number: 1119779